InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Mattes Glenn R., Chairman & CEO. Insider active across 1 companies, notably TFF Pharmaceuticals, Inc.. Aggregated, 3 filings have been published. Total volume traded: €194k. The latest transaction was disclosed on 16 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
€73,26416,000 shares@ €4.57937.8% of flow
Common Stock
SEC:0001213900-22-027791:0·
Ideal exit: 10 Feb 2023 (T+270)
€60,33610,000 shares@ €6.0336100.0% of flow
Common Stock
SEC:0001213900-21-048369·
Ideal exit: 13 Jun 2022 (T+270)
€60,33610,000 shares@ €6.033631.1% of flow
Common Stock
SEC:0001213900-21-048369:0·
Ideal exit: 13 Jun 2022 (T+270)
3 of 3 declarations
About Mattes Glenn R.
Glenn R. Mattes is the Chief Executive Officer of TFF Pharmaceuticals, Inc. He is responsible for the strategic and operational direction of the company, which focuses on developing innovative pharmaceutical solutions. Mattes is committed to advancing the company's mission.
